Metropolitan Life Insurance Company (MetLife)’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,793
| Closed | -$1.09M | – | 2377 |
|
|
2021
Q4 | $1.09M | Buy |
13,793
+198
| +1% | +$16.6K | 0.01% | 897 |
|
|
2021
Q3 | $1.07M | Buy |
13,595
+656
| +5% | +$52.7K | 0.02% | 901 |
|
|
2021
Q2 | $1.02M | Buy |
12,939
+323
| +3% | +$24.7K | 0.01% | 989 |
|
|
2021
Q1 | $951K | Buy |
12,616
+2,145
| +20% | +$157K | 0.01% | 964 |
|
|
2020
Q4 | $689K | Sell |
10,471
-275
| -3% | -$16.1K | 0.01% | 1153 |
|
|
2020
Q3 | $580K | Buy |
10,746
+1,105
| +11% | +$60.7K | 0.01% | 1107 |
|
|
2020
Q2 | $463K | Sell |
9,641
-3,423
| -26% | -$151K | 0.01% | 1271 |
|
|
2020
Q1 | $445K | Sell |
13,064
-703
| -5% | -$38.6K | 0.01% | 1114 |
|
|
2019
Q4 | $862K | Buy |
13,767
+93
| +0.7% | +$5.26K | 0.01% | 984 |
|
|
2019
Q3 | $684K | Sell |
13,674
-1,993
| -13% | -$94.1K | 0.01% | 1097 |
|
|
2019
Q2 | $756K | Buy |
15,667
+30
| +0.2% | +$1.44K | 0.01% | 1059 |
|
|
2019
Q1 | $799K | Buy |
15,637
+14,429
| +1,194% | +$633K | 0.01% | 1010 |
|
|
2018
Q4 | $43.5K | Sell |
1,208
-9
| -0.7% | -$420 | ﹤0.01% | 2513 |
|
|
2018
Q3 | $75.5K | Sell |
1,217
-175
| -13% | -$9.97K | ﹤0.01% | 2529 |
|
|
2018
Q2 | $73.4K | Sell |
1,392
-94
| -6% | -$5.08K | ﹤0.01% | 2413 |
|
|
2018
Q1 | $81.6K | Buy |
1,486
+2
| +0.1% | +$123 | ﹤0.01% | 2380 |
|
|
2017
Q4 | $101K | Sell |
1,484
-56
| -4% | -$3.77K | ﹤0.01% | 2303 |
|
|
2017
Q3 | $110K | Buy |
1,540
+141
| +10% | +$9.82K | ﹤0.01% | 2406 |
|
|
2017
Q2 | $95K | Sell |
1,399
-236
| -14% | -$16.1K | ﹤0.01% | 2515 |
|
|
2017
Q1 | $110K | Hold |
1,635
| – | – | ﹤0.01% | 2436 |
|
|
2016
Q4 | $101K | Sell |
1,635
-37
| -2% | -$2.19K | ﹤0.01% | 2539 |
|
|
2016
Q3 | $90K | Sell |
1,672
-16
| -0.9% | -$806 | ﹤0.01% | 2559 |
|
|
2016
Q2 | $77K | Sell |
1,688
-13
| -0.8% | -$635 | ﹤0.01% | 2620 |
|
|
2016
Q1 | $84K | Hold |
1,701
| – | – | ﹤0.01% | 2429 |
|
|
2015
Q4 | $68K | Hold |
1,701
| – | – | ﹤0.01% | 2523 |
|
|
2015
Q3 | $88K | Hold |
1,701
| – | – | ﹤0.01% | 2595 |
|
|
2015
Q2 | $135K | Sell |
1,701
-2,203
| -56% | -$187K | ﹤0.01% | 2566 |
|
|
2015
Q1 | $321K | Hold |
3,904
| – | – | ﹤0.01% | 1800 |
|
|
2014
Q4 | $346K | Buy |
3,904
+104
| +3% | +$9.42K | ﹤0.01% | 2023 |
|
|
2014
Q3 | $373K | Sell |
3,800
-29
| -0.8% | -$3.26K | ﹤0.01% | 1914 |
|
|
2014
Q2 | $491K | Sell |
3,829
-330
| -8% | -$41.2K | ﹤0.01% | 1836 |
|
|
2014
Q1 | $511K | Buy |
4,159
+737
| +22% | +$84.6K | ﹤0.01% | 1789 |
|
|
2013
Q4 | $375K | Hold |
3,422
| – | – | ﹤0.01% | 2016 |
|
|
2013
Q3 | $333K | Sell |
3,422
-46
| -1% | -$4.24K | ﹤0.01% | 2029 |
|
|
2013
Q2 | $311K | Buy |
+3,468
| New | +$286K | ﹤0.01% | 2019 |
|
Other funds holding ENOV
CB
DCP
SV
SCA
CCMLC
Metropolitan Life Insurance Company (MetLife)'s ENOV Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Enovis (ENOV) in Q1 2022, closing a stake of 13,793 shares — an estimated $1.09M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ENOV in Q2 2013 and held it in 35 quarters. The position peaked at $1.09M in Q4 2021. 298 funds tracked by Wall St. Rank hold ENOV as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Enovis position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 13,793 Enovis shares in Q1 2022, an estimated $1.09M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Enovis in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Enovis position peaked at $1.09M in Q4 2021.
- 298 funds tracked by Wall St. Rank held Enovis as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.